Matches in Wikidata for { <http://www.wikidata.org/entity/Q87932348> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q87932348 description "assaig clínic" @default.
- Q87932348 description "clinical trial" @default.
- Q87932348 description "clinical trial" @default.
- Q87932348 description "clinical trial" @default.
- Q87932348 description "clinical trial" @default.
- Q87932348 description "ensaio clínico" @default.
- Q87932348 description "ensayo clínico" @default.
- Q87932348 description "ensayu clínicu" @default.
- Q87932348 description "essai clinique" @default.
- Q87932348 description "klinisch onderzoek" @default.
- Q87932348 description "клінічне випробування" @default.
- Q87932348 name "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 name "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 type Item @default.
- Q87932348 label "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 label "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 prefLabel "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 prefLabel "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma" @default.
- Q87932348 P1050 Q87932348-20156E62-FCB3-41BE-BE01-76E5638BEC53 @default.
- Q87932348 P1132 Q87932348-EDD2D1B5-878F-4474-9C9E-2ACD5621BF90 @default.
- Q87932348 P1476 Q87932348-6D87D0ED-B26D-4F66-A35D-769B2CC1923B @default.
- Q87932348 P17 Q87932348-28E65F19-C729-41F6-992C-2E1DC49D3D2D @default.
- Q87932348 P17 Q87932348-672BFD38-6FED-4231-AEF1-338C8E6524DB @default.
- Q87932348 P17 Q87932348-9050A765-FA62-4BC6-806B-1FAA75682376 @default.
- Q87932348 P17 Q87932348-992B1E0F-3248-48D4-8CC6-A41B8233277B @default.
- Q87932348 P1813 Q87932348-ECD99180-855E-4B89-8AD9-72B6392D1032 @default.
- Q87932348 P2899 Q87932348-97AF4CA3-B42E-43B5-B3EB-AB8A3B6AC40B @default.
- Q87932348 P3098 Q87932348-8E573722-C1B5-42A2-85AC-679832CB74D6 @default.
- Q87932348 P31 Q87932348-968A2B81-BD84-4666-8D43-8A7BAE7F873E @default.
- Q87932348 P4844 Q87932348-2AB88771-1C8D-4ED1-B400-C950C7FB8B90 @default.
- Q87932348 P4844 Q87932348-8F07F5A9-5A25-4BA9-A084-0914794652A1 @default.
- Q87932348 P4844 Q87932348-A9D685C5-B1D4-494F-9319-EC85EE1494B2 @default.
- Q87932348 P580 Q87932348-767BC10E-4AB2-4C4C-B840-7C95BC7CB30F @default.
- Q87932348 P582 Q87932348-CB6B4E1D-5CF0-4D26-85B5-BFE1348C6D82 @default.
- Q87932348 P6099 Q87932348-30C4ACEB-ECF1-4275-AD6B-7112A9144F9F @default.
- Q87932348 P767 Q87932348-60C90576-A42D-477F-AE89-05A650B04C05 @default.
- Q87932348 P8363 Q87932348-FDDD7BF0-614D-4B78-B465-710B950485E1 @default.
- Q87932348 P1050 Q1077603 @default.
- Q87932348 P1132 "+118" @default.
- Q87932348 P1476 "Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma (the NIPU-study)" @default.
- Q87932348 P17 Q20 @default.
- Q87932348 P17 Q34 @default.
- Q87932348 P17 Q35 @default.
- Q87932348 P17 Q408 @default.
- Q87932348 P1813 "NIPU" @default.
- Q87932348 P2899 "+18" @default.
- Q87932348 P3098 "NCT04300244" @default.
- Q87932348 P31 Q30612 @default.
- Q87932348 P4844 Q2459042 @default.
- Q87932348 P4844 Q3950557 @default.
- Q87932348 P4844 Q7041828 @default.
- Q87932348 P580 "2020-03-15T00:00:00Z" @default.
- Q87932348 P582 "2024-03-15T00:00:00Z" @default.
- Q87932348 P6099 Q42824440 @default.
- Q87932348 P767 Q266423 @default.
- Q87932348 P8363 Q78089383 @default.